tradingkey.logo
tradingkey.logo
Search

Champions Oncology Inc

CSBR
Add to Watchlist
5.960USD
-0.085-1.41%
Close 07/02, 13:00ETQuotes delayed by 15 min
82.77MMarket Cap
LossP/E TTM

Champions Oncology Inc

5.960
-0.085-1.41%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-1.41%

5 Days

-1.97%

1 Month

+4.10%

6 Months

-10.51%

Year to Date

-13.75%

1 Year

-23.29%

Key Figures
5.980Open
6.090High
4.31KVolume
LossP/E TTM
58.08P/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
6.045Prev. Close
5.850Low
14.70KTurnover
17.61P/E Static
19.32P/B
0.00%Div Yield TTM
-7.93%ROA
9.63052wk High
1.19Volume Ratio
4.70MNet Profit
13.89MShares
-0.1725EPS TTM
0.40Beta
-48.05%ROE
5.50052wk Low
3.97%Amplitude
46.65%Gross Margin
82.77MMarket Cap
1.57Reward/Risk
3.97%Risk Rate

Key Insights

Champions Oncology Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 195 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 12.00.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Champions Oncology Inc's Score

Industry at a Glance

Industry Ranking
195 / 387
Overall Ranking
355 / 4564
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Champions Oncology Inc Highlights

StrengthsRisks
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Growing
The company is in a growing phase, with the latest annual income totaling USD 56.94M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Undervalued
The company’s latest PE is -35.04, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 6.66M shares, decreasing 5.85% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
12.000
Target Price
+109.42%
Upside Space

Champions Oncology Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Champions Oncology Inc Info

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Ticker SymbolCSBR
CompanyChampions Oncology Inc
CEOBrainin (Robert)
Websitehttps://championsoncology.com

FAQs

What is the current price of Champions Oncology Inc (CSBR)?

The current price of Champions Oncology Inc (CSBR) is 5.96.

What is the symbol of Champions Oncology Inc?

The ticker symbol of Champions Oncology Inc is CSBR.

What is the 52-week high of Champions Oncology Inc?

The 52-week high of Champions Oncology Inc is 9.63.

What is the 52-week low of Champions Oncology Inc?

The 52-week low of Champions Oncology Inc is 5.50.

What is the market capitalization of Champions Oncology Inc?

The market capitalization of Champions Oncology Inc is 82.77M.

What is the Earnings Per Share (EPS TTM) of Champions Oncology Inc (CSBR)?

The Earnings Per Share (EPS TTM) of Champions Oncology Inc (CSBR) is 0.34.